Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force.

Autor: Vasu S; The Ohio State University, Columbus, Ohio. Electronic address: sumithira.vasu@osumc.edu., Holtan SG; University of Minnesota, Minneapolis, Minnesota., Shimamura A; Boston Children's Hospital, Boston, Massachusetts., Burnworth T; Air Force Lifecycle Management Center, Wright-Patterson Air Force Base, Dayton, Ohio., Whisenton S; American Society of Hematology Sickle cell Initiative, Washington, District of Columbia., Adams S; Christ Hospital, Cincinnati, Ohio., Nuechterlein B; Children's Hospital Colorado, Aurora, Colorado., Mortier N; American Society of Hematology Sickle cell Initiative, Washington, District of Columbia., Foster J; National Marrow Donor Program, Minneapolis, Minnesota., DiFronzo N; National Heart, Lung and Blood Institute, Bethesda, Maryland., Horowitz M; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin., Rizzo D; Center for International Blood and Marrow Transplantation Research, Medical College of Wisconsin, Milwaukee, Wisconsin., Foley A; National Marrow Donor Program, Minneapolis, Minnesota.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2023 Jan; Vol. 29 (1), pp. 5-9. Date of Electronic Publication: 2022 Oct 23.

Optimization of Therapy for Severe Aplastic Anemia Based on Clinical, Biologic, and Treatment Response Parameters: Conclusions of an International Working Group on Severe Aplastic Anemia Convened by the Blood and Marrow Transplant Clinical Trials Network, March 2010

Autor: Pulsipher MA, Young NS, Tolar J, Deeg HJ, Anderlini P, Calado R, Kojima S, Eapen M, Harris R, Scheinberg P, Savage S, Maciejewski JP, Tiu RV, Difronzo N, Horowitz MM, Antin J.H., RISITANO, ANTONIO MARIA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::911acaec9c56d55ed876a70841ac53f9
http://hdl.handle.net/11588/569385

The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes.

Autor: Sekeres MA; Cleveland Clinic, Cleveland, OH, USA., Gore SD; Yale Cancer Center, New Haven, CT, USA., Stablein DM; The Emmes Corporation, Rockville, MD, USA., DiFronzo N; National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Abel GA; Dana-Farber Cancer Institute, Boston, MA, USA., DeZern AE; Johns Hopkins University, Baltimore, MD, USA., Troy JD; Duke University, Durham, NC, USA., Rollison DE; Moffitt Cancer Center, Tampa, FL, USA., Thomas JW; National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Waclawiw MA; National Heart, Lung, and Blood Institute, NIH, Bethesda, MD, USA., Liu JJ; Illinois CancerCare, PC/Heartland NCORP, Peoria, IL, USA., Al Baghdadi T; IHA Hematology Oncology Consultants, Ypsilanti, MI, USA., Walter MJ; Washington University In St. Louis, Saint Louis, MO, USA., Bejar R; Moores Cancer Center, University of California, San Diego, CA, USA., Gorak EJ; Baptist MD Anderson Cancer Center, Jacksonville, FL, USA., Starczynowski DT; Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA., Foran JM; Mayo Clinic, Jacksonville, FL, USA., Cerhan JR; Mayo Clinic, Rochester, MN, USA., Moscinski LC; Moffitt Cancer Center, Tampa, FL, USA., Komrokji RS; Moffitt Cancer Center, Tampa, FL, USA., Deeg HJ; Clinical Research Division, Fred Hutchison Cancer Research Center, Seattle, WA, USA., Epling-Burnette PK; Moffitt Cancer Center, Tampa, FL, USA.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (13), pp. 3161-3171. Date of Electronic Publication: 2019 May 21.

A trial of unrelated donor marrow transplantation for children with severe sickle cell disease.

Autor: Shenoy S; Department of Pediatrics, Washington University School of Medicine, St. Louis Children's Hospital, St. Louis, MO., Eapen M; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Panepinto JA; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.; Children's Hospital of Wisconsin, Milwaukee, WI., Logan BR; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Wu J; The Emmes Corporation, Rockville, MD., Abraham A; Children's National Medical Center, Washington, DC., Brochstein J; Steven and Alexandra Cohen Children's Medical Center, New Hyde Park, NY., Chaudhury S; Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL., Godder K; Department of Pediatrics, Virginia Commonwealth University, Richmond, VA., Haight AE; Department of Pediatrics, Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA., Kasow KA; Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, NC., Leung K; Department of Pediatrics, Baylor College of Medicine, Houston, TX., Andreansky M; Department of Pediatrics, University of Miami, Miami, FL., Bhatia M; Columbia University Medical Center, New York, NY., Dalal J; Children's Mercy Hospital and Clinics, Kansas City, KS., Haines H; Department of Pediatrics, University of Alabama, Birmingham, AL., Jaroscak J; Department of Pediatrics, Medical University of South Carolina, Charleston, SC., Lazarus HM; Department of Internal Medicine, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH., Levine JE; Departments of Internal Medicine and Pediatrics, University of Michigan, Ann Arbor, MI., Krishnamurti L; Children's Hospital of Pittsburgh, Pittsburgh, PA., Margolis D; Children's Hospital of Wisconsin, Milwaukee, WI., Megason GC; University of Mississippi Medical Center, Jackson, MS., Yu LC; Louisiana State University Medical Center, Children's Hospital of New Orleans, New Orleans, LA., Pulsipher MA; Pediatric Blood and Marrow Transplant Consortium, Salt Lake City, UT., Gersten I; The Emmes Corporation, Rockville, MD., DiFronzo N; National Heart, Lung, and Blood Institute, Bethesda, MD., Horowitz MM; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI., Walters MC; UCSF Benioff Children's Hospital, Oakland, CA; and., Kamani N; AABB Center for Cellular Therapies, Bethesda, MD.

Publikováno v: Blood [Blood] 2016 Nov 24; Vol. 128 (21), pp. 2561-2567. Date of Electronic Publication: 2016 Sep 13.

Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study.

Autor: Maximova, Natalia¹ (AUTHOR) natalia.maximova@burlo.trieste.it, Nisticò, Daniela² (AUTHOR), Riccio, Guglielmo² (AUTHOR), Maestro, Alessandra³ (AUTHOR), Barbi, Egidio^1,2 (AUTHOR) egidio.barbi@burlo.trieste.it, Faganel Kotnik, Barbara⁴ (AUTHOR) barbara.faganel@gmail.com, Marcuzzi, Annalisa⁵ (AUTHOR) annalisa.marcuzzi@unife.it, Rimondi, Erika⁶ (AUTHOR) annalisa.marcuzzi@unife.it, Di Paolo, Antonello⁷ (AUTHOR) antonello.dipaolo@med.unipi.it

Publikováno v: Cancers. Jul2023, Vol. 15 Issue 14, p3605. 15p.